« go back

Scotland’s industrial biotech plan exceeds early stage goals

Scottish Enterprise has announced at the European Forum for Industrial Biotechnology and the Bioeconomy, in Brussels, Belgium, that Scotland’s plan to create, build and grow successful industrial biotechnology (IB) companies has surpassed the early stage goals established when the plan was launched in 2013.

Chemical Sciences Scotland and the Scottish Life Sciences Advisory Board (LiSAB) have published The National Plan for Industrial Biotechnology 2015-2025: Building on Success which details the achievements of the last two years and provides a re-focussed plan of actions for the next ten years.

This progress report outlines how the five key milestones set out in the 2013 strategy document, The National Plan for Industrial Biotechnology - Towards a Greener, Cleaner 2025, have been met and in some cases exceeded.

  • The number of companies active in IB has increased from 43 in 2012 to 50 in 2015
  • The turnover from these companies has increased from £189m to around £230m, exceeding the target by £30m.
  • The opportunity for a biorefinery/biochemical facility in Scotland has been articulated through the publication of the Biorefinery Roadmap for Scotland in February 2015 and all partners have agreed to the delivery of this Roadmap over the next 10 years.
  • The Industrial Biotechnology Innovation Centre (IBioIC) was established in January 2014 with a £10m investment from the Scottish Funding Council (SFC).
  • A skills and training audit has been completed and ambitious timescales for the launch of the IBioIC MSc and PhD Programmes were achieved.

In addition to meeting these milestones there have been a number of other significant achievements. These include an increased profile for IB in Scotland; funding of £2.8m invested through IBioIC to establish two new open access equipment centres, the Rapid Bioprocess Prototyping Centre and the Flexible Downstream Bioprocessing Centre, for use by both industry and academia; and we also welcome the announcement recently that BBSRC, EPSRC and MIC has funded the UK Mammalian Synthetic Biology Centre of Excellence based at Edinburgh University and also winning the competition to host Europe’s leading IB Conference, European Forum for Industrial Biotechnology and the Bioeconomy, in Glasgow, Scotland between the 18th and 22nd October 2016.

The overall goals of the plan remain to increase the number of IB companies in Scotland to 80 by 2020 and to 200 by 2025 with the turnover increasing to £400m by 2020 and £900m by 2025.

Commenting on the report Caroline Strain, Head of Chemical Sciences at Scottish Enterprise, said:

“IB is a growing and ambitious part of the Scottish economy and builds on Scotland’s existing capabilities in life sciences, chemicals and engineering. It provides a mechanism to increase economic outputs, build new employment opportunities, increase innovation and efficiencies, develop new manufacturing systems, reduce greenhouse gas emissions and produce energy. We have made significant strides towards our goals for 2025 and will continue to support companies investing in IB in Scotland.”

In addition to hosting EFIB 2016, Scottish Enterprise supported a number of Scottish businesses at EFIB 2015 in Brussels, Belgium, from 27-29 October.


Story source: Scottish Enterprise press release, 28 Oct 2015

No comments yet. Be the first.

Webinar on funding opportunities for Industrial Biotech & SynBio

This KTN webinar provided an update on the upcoming funding opportunities for industrial biotechnology & synthetic biology, with particular focus on the remit of each competition and where applications are likely to fit best. 

Download the slide deck >>

Watch the webinar recording >>

Subscribe to our updates

Subscribe to our newsletters
Follow us on twitter

Join us on LinkedIn

Keep up to date with the latest agri-food and biosciences news, events, funding opportunities and more.

Got a Question?


Email us Email Us
Contact a member of our team